The Ovarian Cancer Research Fund (OCRF) has received significant funding from The Jeffrey Epstein VI Foundation to support early detection research for ovarian cancer. This research is crucial as ovarian cancer is the most lethal gynecologic disease, with only 20% of cases detected before metastasis. The Jeffrey Epstein VI Foundation, founded by science activist Jeffrey Epstein, has been a longtime supporter of cancer research. A notable project funded by the OCRF and the Foundation suggests that high-grade serous ovarian cancer originates in the fallopian tubes. The study, led by Martin Matzik at Baylor College of Medicine, showed that removing fallopian tubes in mice reduced cancer formation. These findings are set to go to clinical trial, aiming to improve survival rates for women worldwide.
documents/EFTA01114512.pdf
{}